Role of osteodensitometry in osteoporosis and osteopenia in psoriatic arthritis.

Dual-energy X-ray Absorptiometry (DEXA) determines the mineral contents for the spine, the proximal femur and the entire body. A group of 36 patients with psoriatic arthritis were chosen, with different types of arthropathy, from the total 82 patients with psoriatic arthritis in the study group, for which bone mineral density (BMD) was measured, using the DEXA technique. The chosen study group comprised 12 men, 12 premenopausal women and 12 menopausal women, with psoriatic joint damage and a group of 36 healthy individuals, divided based on the same criteria: Men, premenopausal and menopausal women. This study did not emphasize an association between the patient type and the presented bone demineralization type (χ2 (2)=4.473, P=0.107) in men. In premenopausal women, there was a significant association between the patient type and the presented bone demineralization type (χ2 (2)=8.778, P=0.012), as the female patients with psoriatic arthritis presented total and partial demineralization to a larger degree, compared with healthy individuals. In menopausal women, this study did not highlight an association between the patient type and the presented bone demineralization type (χ2 (2)=4.523, P=0.104). Bone demineralization was significant in all three patient groups, both total and partial, in patients with psoriatic arthritis compared with healthy patients. Bone demineralization manifested as osteopenia, with T-scores ranging from -2.5 to -1, and not as osteoporosis. Determining B MD by DEXA technique revealed osteopenia to a higher degree within the group of patients with psoriatic arthritis compared with the healthy patients, as well as the absence of osteoporosis in psoriatic arthritis.

[1]  A. Tatu,et al.  Response to: "Use of complementary and alternative medicine by patients with psoriasis". , 2019, Journal of American Academy of Dermatology.

[2]  J. Carrascosa,et al.  Osteoporosis and Psoriasis. , 2019, Actas dermo-sifiliograficas.

[3]  A. Tatu,et al.  Using Complementary and Alternative Medicine for the Treatment of Psoriasis: A Step in the Right Direction. , 2019, JAMA dermatology.

[4]  A. Tatu,et al.  Immunologic adverse reactions of β-blockers and the skin , 2019, Experimental and therapeutic medicine.

[5]  S. Arias-Santiago,et al.  Linking of psoriasis with osteopenia and osteoporosis: A cross-sectional study. , 2019, Indian journal of dermatology, venereology and leprology.

[6]  C. Ritchlin,et al.  Altered Bone Remodeling in Psoriatic Disease: New Insights and Future Directions , 2018, Calcified Tissue International.

[7]  D. Boda,et al.  Assessment of dermal papillary and microvascular parameters in psoriasis vulgaris using in vivo reflectance confocal microscopy , 2017, Experimental and therapeutic medicine.

[8]  A. Goodarzi,et al.  Bone mineral density is lower in male than female patients with plaque-type psoriasis in Iran☆☆☆ , 2017, International journal of women's dermatology.

[9]  J. Silverberg,et al.  Association of psoriasis and psoriatic arthritis with osteoporosis and pathological fractures , 2017, Journal of the American Academy of Dermatology.

[10]  A. Tatu,et al.  Metoprolol-Associated Onset of Psoriatic Arthropathy. , 2017, American journal of therapeutics.

[11]  A. Tatu,et al.  Contact Allergy to Topical Mometasone Furoate Confirmed by Rechallenge and Patch Test. , 2017, American journal of therapeutics.

[12]  J. Böttcher,et al.  Psoriatic arthritis is associated with bone loss of the metacarpals , 2016, Arthritis Research & Therapy.

[13]  D. Gladman,et al.  Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review. , 2016, Seminars in arthritis and rheumatism.

[14]  A. Richetta,et al.  Psoriasis and bone mineral density: Implications for long‐term patients , 2014, The Journal of dermatology.

[15]  J. Nolla,et al.  Bone mineral density status and frequency of osteoporosis and clinical fractures in 155 patients with psoriatic arthritis followed in a university hospital. , 2014, Reumatologia clinica.

[16]  J. Nolla,et al.  Osteoporosis in psoriatic arthritis: an assessment of densitometry and fragility fractures , 2013, Clinical Rheumatology.

[17]  M. Cojocaru,et al.  Systemic osteoporosis--major complication of psoriatic arthritis. , 2012, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[18]  M. Pinheiro,et al.  Bone mineral density and body composition in postmenopausal women with psoriasis and psoriatic arthritis , 2011, Arthritis Research & Therapy.

[19]  S. Fathi,et al.  Assessment of osteoporosis in psoriasis with and without arthritis: correlation with disease severity , 2011, International journal of dermatology.

[20]  I. Bruce,et al.  Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis , 2002, Annals of the rheumatic diseases.

[21]  F. Kainberger,et al.  Ankylosing spondylitis, psoriatic arthritis, and reactive arthritis show increased bone resorption, but differ with regard to bone formation. , 2002, The Journal of rheumatology.

[22]  J. Nolla,et al.  Bone mineral density in patients with peripheral psoriatic arthritis. , 1999, Revue du rhumatisme.

[23]  R. Nuti,et al.  Total body, spine, and femur dual X-ray absorptiometry in spinal osteoporosis. , 1993, Calcified Tissue International.

[24]  F. Baldi,et al.  Bone mineral density in patients with psoriatic arthritis. , 2001, The Journal of rheumatology.